OBX
NASD Obsidian Therapeutics, Inc.$11.77 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.77, $0.69 below the day’s high of $12.46
- YTD change
- -65.38%
- vs 20-day SMA
- -14.99%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-21.80 (-64.12%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 76.4% away from all-time highs of $49.97
- OBX is down 65% since the beginning of the year
- OBX is down 65% over the past 12 months
- OBX is down 33% over the past 1 month
- 97% of all OBX investors are betting against OBX
OBX reads poor: the 12-month move is -64.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.07
- Last 5 days
- -3.84%
- vs 8-day SMA
- -6.64%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.